Ipsilateral breast tumor recurrence (IBTR) is a critical prognostic determinant in breast cancer patients undergoing breast-conserving surgery (BCS). The spatial arrangement of immune, stromal, and malignant cells can influence local recurrence progression and treatment efficacy in IBTR tumors. Here, we performed single-cell spatial transcriptomics on primary breast cancer (PBC) and matched IBTR specimens from 22 patients, comprising 18 true recurrence (TR) and 4 new primary (NP) cases, to generate a comprehensive atlas of over 600,000 cells. Cellular neighborhood (CN) analysis identified a specific tumor cell-stromal region significantly enriched in IBTR tumors. Tumor recurrence was driven by a highly proliferative epithelial cell subpopulation characterized by immune exclusion and invasive features. Spatial analysis uncovered a tumor-stromal region where CD24+ tumor cells spatially intersected with BGN+ cancer-associated fibroblasts (CAFs) alongside upregulation of MDK signaling. In parallel, the BGN+ CAFs displayed enriched CXCL12 pathways, suggesting a potential spatial axis that aligns with local immunosuppressive remodeling and recurrent niche formation. Critically, the spatial colocalization of CD24⁺ tumor cells and BGN⁺ CAFs was validated as an independent predictor of recurrence after BCS. This study delivers a high-resolution spatial landscape of IBTR, uncovering distinct microenvironmental landscapes between TR and NP subtypes, and establishes these spatially defined cellular networks as both mechanistic drivers and translatable prognostic biomarkers.
No takes yet. Share an insight, caveat, or question.
Qu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: